SCHEMBL28752805

SCHEMBL28752805

O=C(Nc1nnc(Cc2ccncc2)c2ccccc12)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FLT1 P17948 13/20 0.64
▸ KDR P35968 13/20 0.64
▸ PDGFRB P09619 12/20 0.64
▸ KIT P10721 11/20 0.64
▸ CSF1R P07333 2/20 0.53
▸ FLT4 P35916 2/20 0.53
▸ CIT O14578 1/20 0.53
▸ EGFR P00533 1/20 0.53
▸ HLA-A P04439 1/20 0.53
▸ RET P07949 1/20 0.53
▸ PDGFRA P16234 1/20 0.53
▸ RPS6KB1 P23443 1/20 0.53
▸ FRK P42685 1/20 0.53
▸ CDK8 P49336 1/20 0.53
▸ DDR1 Q08345 1/20 0.53
▸ STK3 Q13188 1/20 0.53
▸ PTK6 Q13882 1/20 0.53
▸ MAP3K19 Q56UN5 1/20 0.53
▸ CDK19 Q9BWU1 1/20 0.53
▸ MAP3K20 Q9NYL2 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27625198 0.84 KDR (0.57) FLT1KDRPDGFRBKITCSF1R
SCHEMBL27625380 0.83 KDR (0.65) FLT1KDRPDGFRBKITCSF1R
SCHEMBL28021680 0.83 FLT1 (0.54) FLT1KDRPDGFRBKITCSF1R
SCHEMBL27495149 0.80 KDR (0.56) FLT1KDRPDGFRBKITCSF1R
SCHEMBL905590 0.78 FLT1 (1.00) FLT1KDRPDGFRBKITCSF1R
SCHEMBL28073018 0.74 MAPT (0.64) FLT1KDRPDGFRBKITCSF1R
SCHEMBL6606676 0.73 FLT1 (0.81) FLT1KDRPDGFRBKITCSF1R
SCHEMBL27511538 0.72 FLT1 (0.60) FLT1KDRPDGFRBKITCSF1R
SCHEMBL8209289 0.72 KDR (0.70) FLT1KDRPDGFRBKITCSF1R
Vatalanib SCHEMBL6605579 0.71 KDR (0.88) FLT1KDRPDGFRBKITCSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101897662-A The ophthalmic ointment compositions that comprises medicine, ointment base and solubilizing agent/dispersant NOVARTIS AG 2010-12-01 — — CN disclosed
CN-1674868-B Ophthalmic ointment compositions comprising a drug, an ointment base and a solubilizer/dispersant NOVARTIS AG 2010-09-29 — — CN disclosed
CN-1674868-A Ophthalmic ointment compositions comprising a drug, an ointment base and a solubilizer/dispersant NOVARTIS AG (CH) 2005-09-28 — — CN disclosed
Send feedback